Mutations in fibroblast growth factor receptors: Phenotypic consequences during eukaryotic development
- Johns Hopkins Univ. School of Medicine, Baltimore, MD (United States)
Recently, a tremendous amount of excitement and interest has been generated by the rapid succession of discoveries in the human fibroblast growth factor receptor (FGFR) field. In less than a year, mutations in three FGFRs (FGFR1-FGFR3) have been associated with three skeletal dysplasias and four craniosynostotic syndromes. FGFRs are members of the receptor tyrosine kinase family that bind fibroblast growth factors (FGFs). The FGF family consists of structurally related polypeptides that play a key role in numerous aspects of embryogenesis, growth, and homeostasis. FGFs have a potent growth stimulatory and/or differentiation-inducing effect on cells such as those derived from the early-embryonic mesoderm or ectoderm. In addition to mitogenesis and differentiation, FGFs also stimulate chemotaxis, cell survival, and angiogenesis. FGFs mediate cellular responses on binding to and activation of FGFRs. 45 refs., 2 figs., 1 tab.
- OSTI ID:
- 236342
- Journal Information:
- American Journal of Human Genetics, Vol. 57, Issue 4; Other Information: PBD: Oct 1995
- Country of Publication:
- United States
- Language:
- English
Similar Records
S100A13-C2A binary complex structure-a key component in the acidic fibroblast growth factor for the non-classical pathway
Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene